Читать «Биологическая война (Часть 3)» онлайн - страница 295

Wanisch K., Yunez-Munoz. R. J. Integration-deficient Lentiviral vectors: a slow coming of age // The American Society of Gene & Cell Therapy. 2009. V. 17 № 8. P. 1316–1332.

Wanisch K., Ynez-Mucoz R. J. Integration-deficient lentiviral vectors: a slow coming of agt // www.mole-culartherapy.org. 2001 V. 17. № 8. P. 1316–1332.

Wannemacher R. W. Anderson J. B. Inhalation ricin: aerosol procedures, toxicology and therapy // Inhalation toxicology, 2nd ed., eds. H. Salem and S. Katz. 2006. P. 973–980.

Warfield K. L., Swenson D.L., Olinger G.G., Nichols D. K. et al. Gene-specific countermeasures against Ebola virus based on antisense phosphorodiamidate morpholino oligomers // PLoS Pathogens. 2006. V 2. Is. I P. 5–13.

WeaverS. C., KangW.L., Shirako Y. et al. Recombinational history and molecular evolution of western equine encepnalomyelitis complex alphav lruses // J. Virol. 1997 V. 71. P. 613–623.

WeaverS. C., Reisen W. K. Present and future arboviral threats // Antiviral Res 2010. V. 85. № 2 (328. doi: 10.1016/j.antiviral.2009.10.008).

Webster R. Influenza an emerging disease // Emerg. Infect. Dis. 1998. V. 4. № 3. P. 416–419.

Wells W. F. Air-borne infection. II. Droplets and droplet nuclei // Am. J. Hyg. 1934. V. 20. P. 611–618.

Wells W. F., Rateliffe H. L., Crumb C. On the mechanism of droplet nuclei infection. II. Quantitative expenmental air-borne infection in rabbits // Am. J. Hyg. 1948. V- 47. P. 11–28.

Westwood J. C. N., Boulter E. A., Bowen E. T. W et al. Experimental respiratory infection with poxviruses. I.

Clinical virological and epidemiological studies // Br. J. Exp. Pathol. 1966. V. 47. № 5. P. 453–465. Whatmore A., Perrett L., MacMillan A. Characterisation of the genetic diversity of Brucella by multilocus sequencing // BMC Microbiol. 2007 V 7:34 doi:10.1186/1471-2180-7-34.

White J. D., Rooney J. R., Pricket! P. A. et al. Paithogciiesis of experimental respiratory tularemia in monkeys // J. Inf Dis. 1964. V. 47. P. 277–286 Wiener S. L. Strategies ofbiowaffarae defense // Mil. Med. 1987. V. 152. № 1. P. 25–28.

Wiese М., Agostino P., Troco К. M. et al. Neurotoxic alkaloids saxitoxin and its analogs // Mar. Drugs. 2010. V. 8. P. 2185–2211.

Wilhelmseann C., Pitt L. Lesions of acute inhaled lethal ricin intoxication in Rhesus monkeys // Vet. Pathol. 1996. V. 33. P. 296–302

Williams D. A. RAC reviews serious adverse event associated with AAV therapy trial // Mol. Ther. 2007. V. 15. P. 2053–2054.

Williams P., Wallace D. Unit 731: The Jap. Army’s secret of secrets. Lonaon, 1989.

Winn W.C., Walker D. H. The pathology of human Lassa fever // Bull. World Health Organ. 1975. V. 52. P. 535–545.

Win-Shwe Tin-Tin., Fujimaki H. Nanoparticles and neurotoxicity // Int,J. Mol. Sci. 2011. V. 12. P. 6267–6280. Wirth М. C., Georghiou G. P., Federici B. A. CytA enables CryIV endotoxins of Bacillus thuringiensis to overcome nigh levels of CryIV resistance in the mosquito Culexquinquefasuatus // Proc. Natl. Acad. Sci. USA. 1997. V. 94. P. 10536-10540.

Wirtz S., Neurath M. F. Gene transfer approaches for the treatment of inflammatory bowel disease // Gen. Ther. 2003. V. 10. P. 854–860.